How Red Light Therapy (Photobiomodulation) Supports Brain Wellness and Alzheimer’s Research
Sarah Turner is the Founder of CeraThrive, a wellness company specialising in photobiomodulation and its impact on the gut-brain connection. With a background in neuroscience and biohacking, Sarah is dedicated to advancing innovative therapies that optimise health, longevity, and performance.
As science seeks new ways to support brain health and tackle neurodegenerative diseases, red light therapy, also known as photobiomodulation (PBM), is gaining ground as a promising non-invasive approach. By using targeted wavelengths of red and near-infrared light, PBM has been shown to enhance cellular energy, reduce inflammation, and promote neuroprotection. Researchers are now exploring its potential role in cognitive wellness and Alzheimer’s research, with early findings pointing to intriguing possibilities in slowing disease progression and boosting brain resilience.
What is photobiomodulation and how does it work?
Photobiomodulation (PBM), commonly referred to as red light therapy, is an innovative non-invasive therapy that uses specific wavelengths of red and near-infrared (NIR) light to support cellular function. PBM enhances mitochondrial activity, increases ATP production, reduces oxidative stress, and modulates inflammation—all of which are associated with cognitive performance and overall brain wellness.
The role of red light therapy in brain wellness and alzheimer’s research
Emerging research suggests that PBM may influence key processes linked to cognitive function, including:
Reduction of amyloid-beta plaques: Studies indicate that PBM may alter amyloid precursor protein processing, which is associated with amyloid-beta plaque accumulation, a hallmark of Alzheimer’s pathology (PMC).
Cellular energy production: PBM stimulates cytochrome c oxidase, supporting mitochondrial function and optimising neuronal energy metabolism, which is critical in Alzheimer’s research (PubMed).
Neuroprotection and synaptic activity: In preclinical models, PBM has been associated with enhanced synaptic plasticity and reduced neuroinflammatory markers, which may contribute to cognitive performance and Alzheimer’s research (Alzheimer’s Research & Therapy).
Reduction of oxidative stress: PBM is thought to influence oxidative pathways and modulate cellular stress responses, areas of interest in Alzheimer’s studies.
Scientific exploration of PBM, alzheimer’s, and dementia
Several recent studies have examined the relationship between PBM and cognitive function, particularly in Alzheimer’s and dementia research:
A systematic review on PBM and alzheimer’s: This review found evidence suggesting that PBM may have cognitive benefits, though further large-scale studies are needed to refine understanding (PubMed).
Light-based approaches for cognitive support in dementia: Research institutions are exploring how light-based strategies may influence brain activity and neural resilience in Alzheimer’s and dementia (Alzheimer’s Society).
Ongoing research initiatives: Studies continue to investigate the potential of near-infrared light in supporting cognitive performance in individuals with Alzheimer’s and dementia (Alzheimer’s.gov).
Pulsed light stimulation at gamma frequency
Researchers are also exploring the effects of combining PBM with gamma frequency light exposure to further understand its relationship with Alzheimer’s. Some studies suggest that synchronised light and sound stimulation may influence neuroplasticity and brain wave activity (Wiley Online Library).
Future directions in alzheimer’s research and PBM
As interest in non-invasive strategies for Alzheimer’s and dementia grows, PBM continues to be an area of scientific exploration. Key areas for further research include:
Identifying optimal parameters such as wavelength, frequency, and exposure duration.
Understanding long-term effects on cognitive resilience and brain function in Alzheimer’s.
Developing best practices for integrating PBM into broader wellness approaches.
Conclusion
Photobiomodulation is gaining attention as a novel therapy that may support brain wellness and cognitive performance, particularly in Alzheimer’s and dementia research. While ongoing studies continue to explore its potential, early findings suggest it may play a role in optimising neural function and resilience. As research progresses, PBM could become a valuable tool for those looking to explore innovative strategies for maintaining cognitive function.
Call to action
For those interested in exploring PBM in the context of brain wellness and Alzheimer’s research, the CERA System by CeraThrive offers a sophisticated approach. Using pulsed red and near-infrared light at 40Hz gamma frequency, combined with accompanying sound files, the CERA System is designed to support brain performance and cognitive function. To learn more, visit CeraThrive and discover how light-based approaches may contribute to brain wellness.
PMC - Photobiomodulation and its effects on amyloid precursor protein processing and amyloid-beta plaque accumulation.
PubMed - Systematic review on photobiomodulation and cognitive function.
Alzheimer’s Research & Therapy - Effects of PBM on neuroprotection, synaptic activity, and inflammation.
Alzheimer’s Society - Overview of light therapy in dementia care and research.
Alzheimer’s.gov - Ongoing research initiatives and clinical trials on near-infrared light for Alzheimer's risk and cognitive performance.
Wiley Online Library - Research on synchronised light and sound therapy, gamma frequency stimulation, and neuroplasticity.
Sarah Turner, CEO CeraThrive and Red Light Therapy Expert
Sarah Turner is the founder of CeraThrive, a company advancing wellness through photobiomodulation and its impact on the gut-brain connection. With a background in neuroscience and biohacking, she is passionate about exploring innovative therapies to optimise health and performance. Sarah also co-hosts the "Rebel Scientist" podcast, where she explores cutting-edge topics in wellness and longevity.ft”.
